FDA Approves Clonidine XR: First Liquid Non-Stimulant for ADHD

The landscape of ADHD (Attention Deficit Hyperactivity Disorder) treatment has been notably transformed with the FDA’s recent approval of Clonidine XR, marking a significant milestone as the first liquid non-stimulant medication available for managing ADHD symptoms. This development promises to provide a new avenue of relief for those who struggle with ADHD, particularly children and individuals who have difficulty swallowing pills.

Psychiatry Education Forum Academy’s Dr. Harvinder Singh has summarized Clonidine XR (Onyda XR) in the following sections:
(1) FDA Indication
(2) Mechanism of Action
(3) Clonidine vs Guanfacine
(4) Understanding Dosing & Titration
(5) How to Discontinue?
(6) Specific Administration Instructions
(7) Switching from IR to XR formulation
(8) Warnings & Precautions
(9) Important Drug Interactions

Read our blog post for more details: https://psychiatryeducationforum.com/...